✦ LIBER ✦

Survival of Patients With Idiopathic Pulmonary Arterial Hypertension After Listing for Transplantation: Impact of Iloprost and Bosentan Treatment

✍ Scribed by Michael Dandel; Hans B. Lehmkuhl; Sead Mulahasanovic; Yuguo Weng; Dagmar Kemper; Onnen Grauhan; Christoph Knosalla; Roland Hetzer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of patients with primary pulmona

✍ M. Dandel; H.B. Lehmkuhl; Y. Weng; S. Mulahasanovic; H. Böttcher; C. Knosalla; O 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 65 KB

160: Long-term survival with end-stage i

✍ M. Dandel; H.B. Lehmkuhl; S. Mulahasanovic; Y. Weng; O. Grauhan; C. Knosalla; R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

290: Impact of Aggressive Management on

✍ M. de Perrot; J. Granton; A.F. Pierre; K. McRae; T.K. Waddell; K. Yasufuku; C. W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Long-Term Outcome of Bosentan Treatment

✍ Reda E. Girgis; Stephen C. Mathai; Jerry A. Krishnan; Fredrick M. Wigley; Paul M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Continuous intravenous iloprost to rever

✍ Ralf Ewert; Christian F. Opitz; Roland Wensel; Jörg Winkler; Michael Halank; Ste 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 190 KB

316: Survival with Idiopathic Pulmonary

✍ M. Dandel; H.B. Lehmkuhl; S. Mulahasanovic; Y. Weng; C. Knosalla; O. Grauhan; D. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 161 KB